Actively Recruiting
Study of Near-Infrared Light Treatment to Improve Brain Blood Flow in Adults with Major Depressive Disorder
Led by NYU Langone Health · Updated on 2026-02-05
120
Participants Needed
3
Research Sites
8 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying if applying near infrared energy to the forehead can change blood flow in the brains of people with Major Depressive Disorder MDD. Near infrared energy is similar to light but invisible to the eye. This multi-center study involves about 60 adults with MDD undergoing MRI scans during transcranial photobiomodulation tPBM before and after treatment. Participants are randomly assigned to receive either active tPBM delivering near-infrared radiation at a dose of 291.7 mWcm2 for 333 seconds or a sham treatment with no radiation, over 16 sessions. All participants receive tPBM at the first and last visits. The treatment course spans multiple visits, with the active or sham treatment given from visit 2 to 18. During the study, participants undergo brain imaging and depression rating assessments at baseline and at various visits up to week 10. Researchers measure changes in cerebral blood flow and depression severity using the Montgomery-Asberg Depression Rating Scale. Safety and adherence are monitored throughout, with the study lasting about 10 weeks per participant.
CONDITIONS
Brief Title
Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
Research Team
D
Dan Iosifescu, MD
A
Anna Peterson
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here